Compagnie Lombard Odier SCmA’s Immunogen Inc IMGN Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,849,772	Closed	-$15M	–	704
2021 Q1	$15M	Buy	+1,849,772	New	+$15.1M	0.33%	62
2017 Q1	–	Sell	-1,050	Closed	-$2K	–	853
2016 Q4	$2K	Hold	1,050	–	–	﹤0.01%	792
2016 Q3	$3K	Hold	1,050	–	–	﹤0.01%	883
2016 Q2	$3K	Hold	1,050	–	–	﹤0.01%	876
2016 Q1	$9K	Hold	1,050	–	–	﹤0.01%	896
2015 Q4	$14K	Hold	1,050	–	–	﹤0.01%	827
2015 Q3	$10K	Hold	1,050	–	–	﹤0.01%	751
2015 Q2	$15K	Sell	1,050 -1,050	-50%	-$11.5K	﹤0.01%	741
2015 Q1	$19K	Buy	+2,100	New	+$15.2K	﹤0.01%	867
2014 Q2	–	Sell	-900	Closed	-$13K	–	907
2014 Q1	$13K	Buy	+900	New	+$14.2K	﹤0.01%	812

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Compagnie Lombard Odier SCmA's IMGN Position: Q2 2021 in Review

Compagnie Lombard Odier SCmA sold out of Immunogen Inc (IMGN) in Q2 2021, closing a stake of 1,849,772 shares — an estimated $15M sold.

Compagnie Lombard Odier SCmA first reported a position in IMGN in Q1 2014 and held it in 10 quarters. The position peaked at $15M in Q1 2021. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

Compagnie Lombard Odier SCmA reported no remaining Immunogen Inc position as of Q2 2021 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 1,849,772 Immunogen Inc shares in Q2 2021, an estimated $15M.
Compagnie Lombard Odier SCmA first reported a position in Immunogen Inc in Q1 2014 and held it in 10 quarters.
Compagnie Lombard Odier SCmA's Immunogen Inc position peaked at $15M in Q1 2021.
214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2021, filed 15 Jul 2021.